Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: old 'n cranky who wrote (9922)	2/26/2018 8:49:01 AM
From: donpat	Read Replies (1) \| Respond to of 12873

Looks like normal business to me. Mulligans are not involved as I see it. further modeling and analysis be performed incorporating additional assumptions that reflect our situation more closely than in the model that was presented." "Model that was presented" - by whom to whom? I have no idea, somebody in control obviously, BOD, Diwan, Seymour, all or one or more. Sounds like something changed!! What, why; whatever it looks like Myers is continuing so it ain't her doing; she performed well enough to do the rethink. Perhaps Seymour leaving occasioned the new review. Perhaps the entry of Glaxo and/or BMS into the picture? Something quite juicy IMHHO.

To: old 'n cranky who wrote (9922)	4/16/2018 11:47:51 AM
From: donpat	Read Replies (2) \| Respond to of 12873

I would think this is all in aid of raising financing for the FDA stages afoot. And that such money will most likely require a cleanup of the Allexcel - Theracour- NanoViricides IP jumble. Diwan, I suggest will need to make up his mind once and for all where his loyalties lie if he seriously expects to get 100s of $ Millions for NNVC. My suggestion: NanoViricides buy out Allexcel and Theracour and integrate them entirely into NNVC. And in the process, open up the company to all aspects of the technolgy - viral AND cancer and ALL the rest of the possibilities. If that requires a name change to NanoTheracour or whatever, to include nonviral aspects, so be it. Cleanliness is next to godliness!! And right now, NNVC's corporate structure is anything but clean. And money men will stay away in droves till it is spic and span. Right, Carolyn???